Results 261 to 270 of about 126,740 (294)
Toward Personalized Nanomedicine: The Critical Evaluation of Micro and Nanodevices for Cancer Biomarker Analysis in Liquid Biopsy [PDF]
Small, 2023 Liquid biopsy for the analysis of circulating cancer biomarkers (CBs) is a major advancement toward the early detection of cancer. In comparison to tissue biopsy techniques, liquid biopsy is relatively painless, offering multiple sampling opportunities ...
Muhammad J A Shiddiky
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Precision Oncology, 2022
The molecular landscape of the tumors has been typically established using the surgical or biopsy tissue samples resulting in a sampling bias offering only a single snapshot of tumor heterogeneity from the tissue-based tumor profiles.
Rebecca A. Snyder +2 more
+4 more sources
The molecular landscape of the tumors has been typically established using the surgical or biopsy tissue samples resulting in a sampling bias offering only a single snapshot of tumor heterogeneity from the tissue-based tumor profiles.
Rebecca A. Snyder +2 more
+4 more sources
The potential of liquid biopsies
Current Opinion in Oncology, 2016This article discusses the current status and applications of liquid biopsy in nonsmall cell lung cancer (NSCLC).The discovery of genetic alterations which are responsible for the development and progression of NSCLC led to the identification of a new generation of molecular biomarkers.
Anna, Buder +2 more
openaire +2 more sources
Radiology
Knowledge of recent advances in liquid biopsy techniques and clinical trial results is essential to understand the potential of analytes such as cell-free and circulating tumor DNA for the management of different cancers and their future role within an integrated diagnostic approach.
Marius E. Mayerhoefer +3 more
openaire +2 more sources
Knowledge of recent advances in liquid biopsy techniques and clinical trial results is essential to understand the potential of analytes such as cell-free and circulating tumor DNA for the management of different cancers and their future role within an integrated diagnostic approach.
Marius E. Mayerhoefer +3 more
openaire +2 more sources
The evolving role of liquid biopsy in lung cancer [PDF]
Lung Cancer, 2022 Liquid biopsy has revolutionized the management of cancer patients. In particular, liquid biopsy-based testing has proven to be highly beneficial for identifying actionable cancer markers, especially when solid tissue biopsies are insufficient or ...
Umberto Malapelle +21 more
exaly +2 more sources
Liquid Biopsy in the Clinical Management of Cancers [PDF]
International Journal of Molecular SciencesLiquid biopsy, a noninvasive diagnosis that examines circulating tumor components in body fluids, is increasingly used in cancer management. An overview of relevant literature emphasizes the current state of liquid biopsy applications in cancer care ...
Kei-See (Kasey) Chung +3 more
exaly +2 more sources
Clinica Chimica Acta
Lung cancer is a highly prevalent malignancy worldwide and the primary cause of mortality. The absence of systematic and standardized diagnostic approaches for identifying potential pulmonary nodules, early-stage cancers, and indeterminate tumors has led clinicians to consider tissue biopsy and pathological sections as the preferred method for clinical
Lan, Li +7 more
openaire +2 more sources
Lung cancer is a highly prevalent malignancy worldwide and the primary cause of mortality. The absence of systematic and standardized diagnostic approaches for identifying potential pulmonary nodules, early-stage cancers, and indeterminate tumors has led clinicians to consider tissue biopsy and pathological sections as the preferred method for clinical
Lan, Li +7 more
openaire +2 more sources
Actas Urológicas Españolas (English Edition), 2016
A S, Salinas Sánchez +3 more
openaire +2 more sources
A S, Salinas Sánchez +3 more
openaire +2 more sources